Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00160342 · ClinicalTrials.gov registry record · Phase 2
Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes
A Phase 2 study, sponsored by Solvay Pharmaceuticals.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,251
- Enrollment target
NCT00160342: Completed Phase 2 study, sponsored by Solvay Pharmaceuticals.
NCT00160342 is a Phase 2 study that has completed, run by Solvay Pharmaceuticals. The registered enrollment target is 1,251 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (841% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00160342, a Phase 2 study, has completed, sponsored by Solvay Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,251 participants
- Enrollment target
Study Summary
This is a research study to evaluate the effectiveness, safety and side effects of several dose levels of esterified estrogens (EE) and methyltestosterone (MT) given individually and in combination compared to a placebo (a tablet with no active drug in it) as a possible treatment for vasomotor symptoms (such as hot flushes and flushing) of menopause. EE and testosterone are two hormones which are typically deficient in menopausal women
Interventions
- DRUG Esterified Estrogens (EE) and Methyltestosterone (MT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,251 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-09 |
| Phase | Phase 2 |
What the finished NCT00160342 record still lists
NCT00160342 is an interventional study that assigns participants to a tested intervention. Its 1,251 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (841% higher).
The record links to 0 conditions, and to 1 intervention - of which Esterified Estrogens (EE) and Methyltestosterone (MT) is the first listed.
NCT00160342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00160342 about?
NCT00160342 is a clinical study titled "Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes". This is a research study to evaluate the effectiveness, safety and side effects of several dose levels of esterified estrogens (EE) and methyltestosterone (MT) given individually and in combination compared to a placebo (a tablet with no active drug in it) as a possible treatment for vasomotor sympt...
What is the current status of trial NCT00160342?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,251 participants. The study started on 2005-06. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00160342?
The interventions under investigation include: Esterified Estrogens (EE) and Methyltestosterone (MT) (DRUG).
Who is sponsoring clinical trial NCT00160342?
This trial is sponsored by Solvay Pharmaceuticals, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00160342's enrollment target sits among peer trials
1,251 16th of 2000 higher than 1,985 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia